We will discuss Ray as an active learning orchestrator for protein engineering in the drug/medicine discovery process. In particular, we will look at the deployment of systems that involve active-learning feedback between sequence-to-sequence transformers, Alphafold driven sequence-to-structure prediction, and, more broadly, how these two deep learning methods are revolutionizing the field.
Stanley Bishop is an ML-nerd contributor to the open source-project DeepChem.io, which works to democratize deep learning for science.